These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38727982)

  • 1. Pharmacotherapy in Stress Urinary Incontinence; A Literature Review.
    Tabei SS; Baas W; Mahdy A
    Curr Urol Rep; 2024 Jul; 25(7):141-148. PubMed ID: 38727982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
    Alberti C
    G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations in pharmacotherapy for stress urinary incontinence.
    Cannon TW; Yoshimura N; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of pure stress urinary incontinence: a narrative review.
    Malallah MA; Al-Shaiji TF
    Int Urogynecol J; 2015 Apr; 26(4):477-85. PubMed ID: 25630399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do we know about duloxetine's mode of action? Evidence from animals to humans.
    Schuessler B
    BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of duloxetine on female sexual functions in the treatment of stress incontinence.
    Biyikoglu M; Kettas E; Sesli M; Senel S; Cayan S; Akbay E
    Arch Gynecol Obstet; 2023 Sep; 308(3):1037-1042. PubMed ID: 37386151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for stress urinary incontinence : present and future options.
    Zinner NR; Koke SC; Viktrup L
    Drugs; 2004; 64(14):1503-16. PubMed ID: 15233589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
    Puyol M; Collado A
    Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
    Schlenker B; Gratzke C; Reich O; Schorsch I; Seitz M; Stief CG
    Eur Urol; 2006 Jun; 49(6):1075-8. PubMed ID: 16481094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.
    Kotecha P; Sahai A; Malde S
    Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of stress incontinence].
    Jost WH; Marsalek P; Michel MC
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine for management of stress urinary incontinence.
    Guay DR
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary incontinence: pharmacotherapy options.
    Smith AL; Wein AJ
    Ann Med; 2011; 43(6):461-76. PubMed ID: 21639723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.